Table 25 (abstract P64). See text for description
From: Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one
MTX with active disease (n = 4) | MTX with clinical remission (n = 10) | t-Test (p-value) | MTX + TNFi with active disease (n = 19) | MTX + TNFi with clinical remission (n = 14) | t-Test (p-value) | |
|---|---|---|---|---|---|---|
% change from baseline of switched memory B cells (±SD) | 42%(±35) | 29.9%(±34) | 0.55 | 41%(±32) | 9.8%(±25) | 0.0047 |
Slope (indicating the mean % change of switched memory B cells in 12 months) (±SD) | 0.43(±0.35) | 0.42(±0.38) | 0.95 | 0.39(±0.32) | 0.09(±0.34) | 0.015 |